354.Cardiology: iRhythm CEO Quentin Blackford on Scaling proactive & predictive care with AI in cardiology

In this episode, Quentin Blackford, CEO of iRhythm, shares how his company is disrupting cardiology with a wearable patch that captures over a billion heartbeats. He explains how AI scans medical history to find undiagnosed patients with 92% accuracy, why their platform operates at 71% margins, and how they're expanding into sleep apnea detection. Quentin also dives into the shift from specialist to primary care, the upcoming move to direct-to-consumer, and the surprising influence of wearables like Apple Watch. If you're curious about the next wave of health tech and how to build a scalable medtech company, this conversation is packed with insights.Episode Breakdown:00:00 – Intro: Why AI + Software Are Reshaping MedTech00:45 – Meet Quentin Blackford, CEO & President of iRhythm02:15 – Quentin’s Career Path: Zimmer, NuVasive, Dexcom04:50 – Why Traditional Holter Monitoring Falls Short06:10 – Zio Patch Explained: Long-Term Continuous Monitoring08:05 – The Scale of iRhythm’s Data Advantage18:35 – Rising Arrhythmias in Younger Populations20:20 – EHR & Epic Integration: Reducing Physician Friction22:50 – Sleep Apnea Detection Through Cardiac Data32:15 – Post-COVID Shift Toward Proactive Healthcare34:35 – Consumer Wearables as Entry Points to Care37:20 – Why Human Review Still Matters in AI Diagnostics39:10 – IDTF Model Explained & Clinical Oversight41:05 – Revenue Growth, Margins & Business Model Evolution43:10 – International Expansion: UK, Japan & Reimbursement45:05 – SaaS-Like Economics in Modern MedTech47:10 – From Devices to Platforms: AI Care Pathways49:05 – System-Wide Cost Savings & Patient Selection51:20 – M&A Strategy & Corporate Venture Thinking53:40 – Keys to iRhythm’s Profitability Turnaround55:30 – Leadership Lessons From Scaling MedTech57:20 – Future of Cardiac Monitoring & AI59:10 – Final Advice for Founders & Operators01:00:04 – Closing Thoughts & Episode Wrap-UpAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #digitalhealth #aIinhealthcare #cardiology #medicaldevices